Bridging the gap using telemedicine: optimizing an existing autologous hematopoietic SCT unit into an allogeneic hematopoietic SCT unit in Paraguay with the help of the WBMT.
作者信息
Frutos Cristobal, Enciso Maria Elvira, von Glasenapp Alana, Quiroz Alfredo, Batista Jorge, Niederwieser Dietger
机构信息
Instituto de Previsión Social, Asuncion, Paraguay and.
Worldwide Network for Blood and Marrow Transplantation, Bern, Switzerland.
出版信息
Blood Adv. 2019 Dec 6;3(Suppl 1):45-47. doi: 10.1182/bloodadvances.2019GS121781.
Abstract
摘要
相似文献
1
Bridging the gap using telemedicine: optimizing an existing autologous hematopoietic SCT unit into an allogeneic hematopoietic SCT unit in Paraguay with the help of the WBMT.利用远程医疗弥合差距：在世界骨髓移植协会的帮助下，将巴拉圭现有的自体造血干细胞移植单元优化为异基因造血干细胞移植单元。
Blood Adv. 2019 Dec 6;3(Suppl 1):45-47. doi: 10.1182/bloodadvances.2019GS121781.
2
Outcomes of modified-eam conditioned autologous non-cryopreserved hematopoietic sct for lymphoma. A retrospective single-centre study.改良伊登方案预处理的自体非冷冻保存造血干细胞移植治疗淋巴瘤的疗效。一项回顾性单中心研究。
Bone Marrow Transplant. 2018 Dec;53(12):1596-1598. doi: 10.1038/s41409-018-0243-0. Epub 2018 Jun 12.
3
Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.采用简化方法的难治性或复发性淋巴瘤患者门诊接受低强度异基因干细胞移植与自体干细胞移植的比较。
Ann Hematol. 2010 Oct;89(10):1045-52. doi: 10.1007/s00277-010-0986-1. Epub 2010 May 21.
4
Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.改良的脑电活动图作为淋巴瘤患者接受自体造血干细胞移植的预处理方案。
Bone Marrow Transplant. 2018 Jan;53(1):91-93. doi: 10.1038/bmt.2017.206. Epub 2017 Oct 2.
5
Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective.慢性淋巴细胞白血病的干细胞移植：1999年的观点
Ann Oncol. 2000;11 Suppl 1:49-53.
6
Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation.采用自体造血干细胞移植继以异基因造血干细胞微量移植治疗急性混合细胞白血病。
Bone Marrow Transplant. 2014 Jul;49(7):984-5. doi: 10.1038/bmt.2014.74. Epub 2014 Apr 14.
7
Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents.重振而非重新发明轮子：在新型药物时代增强挽救性自体干细胞移植对多发性骨髓瘤的影响。
Bone Marrow Transplant. 2015 Oct;50(10):1269-70. doi: 10.1038/bmt.2015.175. Epub 2015 Aug 3.
8
Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. Respond to author.针刺疗法减轻接受自体造血干细胞移植的多发性骨髓瘤患者的症状负担：一项随机假针刺对照试验。回复作者。
Support Care Cancer. 2019 Sep;27(9):3171-3172. doi: 10.1007/s00520-019-04732-1. Epub 2019 Mar 13.
9
Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP).《意大利普利亚血液学网络（REP）回顾性多中心研究：减低强度预处理异基因造血干细胞移植治疗霍奇金淋巴瘤的结果》。
Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):35-40. doi: 10.1016/j.clml.2018.08.012. Epub 2018 Sep 12.
10
What is the role of apheresis technology in stem cell transplantation?单采技术在干细胞移植中起什么作用？
Transfus Apher Sci. 2017 Dec;56(6):788-794. doi: 10.1016/j.transci.2017.11.007. Epub 2017 Nov 8.
引用本文的文献
1
Increasing access to allogeneic hematopoietic cell transplant: an international perspective.增加异体造血细胞移植的可及性：国际视角。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):264-274. doi: 10.1182/hematology.2021000258.
2
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.150 万例造血干细胞移植：利用非血缘关系供者使全球获得持续和差异化改善。
Haematologica. 2022 May 1;107(5):1045-1053. doi: 10.3324/haematol.2021.279189.
Zotero 插件